| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |